← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Allyx Therapeutics Inc.
New Haven, CT
$5,367,450
Total funding
2
Grants
Funding over time
peak $1.7M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$5,367,450 · 2
By mechanism
SB1$3,347,703 · 1
R44$2,019,747 · 1
Investigators at Allyx Therapeutics Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Clinical evaluation of BMS-984923 metabolism.$1,678,603
SB1 · FY2024 · AG
Clinical evaluation of BMS-984923 metabolism.$1,669,100
SB1 · FY2025 · AG
BMS-984923 Non-Clinical Development to Support Phase 2 Trials$1,339,527
R44 · FY2023 · AG
BMS-984923 Non-Clinical Development to Support Phase 2 Trials$680,220
R44 · FY2022 · AG